Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple cuff reduce hip fracture complications?

NCT ID NCT07178041

Symptom relief Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a treatment called Remote Ischaemic Conditioning (RIC) for people recovering from hip fracture surgery. RIC involves inflating a blood pressure cuff on the arm or leg for short periods to trigger the body's own protective responses. The trial will include 12 adults and aims to see if the treatment is safe, tolerable, and practical to deliver during a hospital stay. If successful, it could lead to a larger study exploring whether RIC reduces common complications like infection and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote Ischaemic Conditioning (blood pressure cuff inflation on arm or leg)
What this could lead to
If it works, this could point toward a simple, low-cost way to reduce complications like infection and improve recovery after hip fracture.
What could go wrong
This is a very small feasibility study with only 12 participants, so results may not apply widely. The treatment may not show clear benefits or could cause discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (aged \> 18 years) * Participant has had a hip fracture identified on X-ray or computed tomography (CT) scan. * Qualifying hip fracture has not occurred more than 7 days prior to enrollment. * Able to give written informed consent. * In the opinion of the treating physician would be able to conform to the study protocol and procedures. Exclusion Criteria: * History or presence of significant peripheral vascular disease in the limb conditioned. * History or presence of complex neuropathic pains or peripheral neuropathy in the limb conditioned. * Presence of lymphoedema in the limb conditioned. * Presence of skin ulceration to the limb conditioned. * Uncontrolled arrhythmia, hypertension, diabetes or angina. * Third degree heart block or progressive heart failure. * Acute aortic dissection, myocarditis, or pericarditis. * Acute deep vein thrombosis, pulmonary embolism. * Suspected or known dissecting aneurysm. * Stroke or TIA myocardial infarction in the last 4 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip fracture

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sheffield Teaching Hospitals NHS Foundation Trust

    RECRUITING

    Sheffield, South Yorkshire, S5 7AU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.